Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Disk | 8 | 2022 | 421 | 0.980 |
Why?
|
| Glaucoma, Open-Angle | 11 | 2022 | 742 | 0.920 |
Why?
|
| Intraocular Pressure | 11 | 2022 | 1304 | 0.480 |
Why?
|
| Tensile Strength | 1 | 2010 | 332 | 0.340 |
Why?
|
| Visual Fields | 9 | 2022 | 1063 | 0.310 |
Why?
|
| Sutures | 1 | 2010 | 283 | 0.310 |
Why?
|
| Sodium Chloride | 1 | 2010 | 580 | 0.310 |
Why?
|
| Aniridia | 1 | 2008 | 36 | 0.300 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2010 | 354 | 0.280 |
Why?
|
| Smallpox | 1 | 2006 | 43 | 0.250 |
Why?
|
| Vaccinia | 1 | 2006 | 71 | 0.250 |
Why?
|
| Nails | 2 | 2018 | 298 | 0.250 |
Why?
|
| Optic Nerve Diseases | 2 | 2020 | 342 | 0.250 |
Why?
|
| Tomography, Optical Coherence | 7 | 2022 | 2954 | 0.250 |
Why?
|
| Eye Infections, Viral | 1 | 2006 | 61 | 0.240 |
Why?
|
| Exfoliation Syndrome | 2 | 2017 | 113 | 0.240 |
Why?
|
| Glaucoma | 4 | 2013 | 1194 | 0.230 |
Why?
|
| Bruch Membrane | 3 | 2019 | 65 | 0.220 |
Why?
|
| Cataract Extraction | 4 | 2016 | 464 | 0.200 |
Why?
|
| Capillaries | 3 | 2021 | 755 | 0.170 |
Why?
|
| Optic Disk Drusen | 1 | 2017 | 38 | 0.140 |
Why?
|
| Retinal Vessels | 2 | 2020 | 863 | 0.130 |
Why?
|
| Diabetic Retinopathy | 2 | 2016 | 1300 | 0.130 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2017 | 192 | 0.120 |
Why?
|
| Tonometry, Ocular | 4 | 2019 | 238 | 0.120 |
Why?
|
| Regional Blood Flow | 1 | 2018 | 1479 | 0.120 |
Why?
|
| Pseudophakia | 1 | 2013 | 61 | 0.110 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2013 | 24 | 0.110 |
Why?
|
| Skin Abnormalities | 1 | 2013 | 60 | 0.100 |
Why?
|
| Refraction, Ocular | 1 | 2013 | 188 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 2971 | 0.100 |
Why?
|
| Phacoemulsification | 1 | 2013 | 151 | 0.100 |
Why?
|
| Microcirculation | 1 | 2017 | 1282 | 0.100 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2013 | 192 | 0.100 |
Why?
|
| Microvessels | 3 | 2021 | 585 | 0.100 |
Why?
|
| Visual Field Tests | 3 | 2019 | 415 | 0.090 |
Why?
|
| Visual Acuity | 3 | 2020 | 2714 | 0.090 |
Why?
|
| Nylons | 1 | 2010 | 47 | 0.090 |
Why?
|
| Polypropylenes | 1 | 2010 | 63 | 0.090 |
Why?
|
| Polyglactin 910 | 1 | 2010 | 56 | 0.090 |
Why?
|
| Retinal Ganglion Cells | 3 | 2022 | 810 | 0.090 |
Why?
|
| Sunlight | 2 | 2014 | 337 | 0.090 |
Why?
|
| Ophthalmology | 1 | 2016 | 560 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1101 | 0.080 |
Why?
|
| Microscopic Angioscopy | 2 | 2018 | 20 | 0.070 |
Why?
|
| Coffee | 1 | 2012 | 594 | 0.070 |
Why?
|
| Hyphema | 1 | 2007 | 26 | 0.070 |
Why?
|
| Caffeine | 1 | 2012 | 703 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 4052 | 0.070 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 26325 | 0.070 |
Why?
|
| Photosensitivity Disorders | 1 | 2007 | 79 | 0.070 |
Why?
|
| Anterior Chamber | 1 | 2007 | 194 | 0.070 |
Why?
|
| Blood Pressure | 4 | 2018 | 8531 | 0.070 |
Why?
|
| Nerve Fibers | 2 | 2020 | 706 | 0.060 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2007 | 75 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2007 | 340 | 0.060 |
Why?
|
| Eye Injuries | 1 | 2007 | 228 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 2007 | 358 | 0.060 |
Why?
|
| Case-Control Studies | 6 | 2020 | 22254 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 2420 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 1168 | 0.050 |
Why?
|
| Aged | 16 | 2020 | 171319 | 0.050 |
Why?
|
| Cataract | 2 | 2014 | 837 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2016 | 6331 | 0.050 |
Why?
|
| Scotoma | 1 | 2022 | 128 | 0.050 |
Why?
|
| Trabeculectomy | 1 | 2003 | 174 | 0.050 |
Why?
|
| Humans | 26 | 2022 | 767040 | 0.050 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 387 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 807 | 0.040 |
Why?
|
| Heart Rate | 1 | 2012 | 4209 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2016 | 4859 | 0.040 |
Why?
|
| Middle Aged | 15 | 2020 | 223233 | 0.040 |
Why?
|
| Ocular Hypertension | 2 | 2012 | 211 | 0.040 |
Why?
|
| Female | 19 | 2022 | 396660 | 0.040 |
Why?
|
| Cornea | 1 | 2007 | 1316 | 0.040 |
Why?
|
| Male | 19 | 2022 | 364203 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4546 | 0.040 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 59548 | 0.040 |
Why?
|
| Benchmarking | 2 | 2016 | 1056 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2020 | 54886 | 0.040 |
Why?
|
| Angiography | 1 | 2022 | 1597 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2017 | 241 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2020 | 81659 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 208 | 0.030 |
Why?
|
| Internship and Residency | 2 | 2016 | 5947 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 12250 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2353 | 0.030 |
Why?
|
| Adult | 10 | 2018 | 223317 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 2014 | 180 | 0.030 |
Why?
|
| Cloprostenol | 1 | 2013 | 21 | 0.030 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2019 | 1086 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2006 | 3070 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2014 | 310 | 0.030 |
Why?
|
| Israel | 1 | 2014 | 726 | 0.020 |
Why?
|
| Occupations | 1 | 2014 | 516 | 0.020 |
Why?
|
| Gonioscopy | 1 | 2012 | 157 | 0.020 |
Why?
|
| Lenses, Intraocular | 1 | 2013 | 141 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2014 | 564 | 0.020 |
Why?
|
| Eyelids | 1 | 2013 | 278 | 0.020 |
Why?
|
| Amides | 1 | 2013 | 451 | 0.020 |
Why?
|
| Potassium | 1 | 2014 | 1314 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2013 | 403 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13646 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 1156 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2013 | 1824 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 12069 | 0.020 |
Why?
|
| Risk Factors | 5 | 2016 | 74886 | 0.020 |
Why?
|
| Antibody-Producing Cells | 1 | 2007 | 140 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4616 | 0.020 |
Why?
|
| Beverages | 1 | 2012 | 819 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2105 | 0.020 |
Why?
|
| Infant | 1 | 2008 | 36485 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2007 | 479 | 0.020 |
Why?
|
| Sjogren's Syndrome | 1 | 2007 | 240 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 42606 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2007 | 1062 | 0.010 |
Why?
|
| Blood | 1 | 2007 | 596 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2014 | 2116 | 0.010 |
Why?
|
| Child | 3 | 2008 | 80771 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 30238 | 0.010 |
Why?
|
| Sweden | 1 | 2007 | 1382 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8890 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9660 | 0.010 |
Why?
|
| Autoantigens | 1 | 2007 | 890 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9362 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6421 | 0.010 |
Why?
|
| Incidence | 2 | 2011 | 21526 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 13035 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3804 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20169 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12451 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29963 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12790 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 6777 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 2160 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 39317 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15824 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18063 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 4499 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 3778 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 9081 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 15851 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 65295 | 0.000 |
Why?
|
| Adolescent | 2 | 2007 | 89046 | 0.000 |
Why?
|
| United States | 1 | 2014 | 72971 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 40154 | 0.000 |
Why?
|
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_